KIR and HLA-C Interactions Promote Differential Dendritic Cell Maturation and Is a Major Determinant of Graft Failure following Kidney Transplantation

KIR and HLA-C Interactions Promote Differential Dendritic Cell Maturation and Is a Major Determinant of Graft Failure following Kidney Transplantation

Bibliographic Details
Main Authors:	Hanvesakul, Raj, Kubal, Chandrashekhar, Moore, Jason, Neil, Desley, Cook, Mark, Ball, Simon, Briggs, David, Moss, Paul, Cockwell, Paul
Format:	Online
Language:	English
Published:	Public Library of Science 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166139/

Similar Items

KIR/HLA Interactions and Pathogen Immunity
by: Jamil, Khaleel M., et al.
Published: (2011)

Activating KIR/HLA complexes in classic Kaposi's Sarcoma
by: Guerini, Franca R, et al.
Published: (2012)

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy
by: Jarduli, Luciana Ribeiro, et al.
Published: (2013)

Editorial: Role of HLA and KIR in Viral Infections
by: de Wit, Jelle, et al.
Published: (2016)

KIR-HLA class I combinations in JIA-associated uveitis
by: Parsa, Miriam, et al.
Published: (2012)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
by: Hirayasu, Kouyuki, et al.
Published: (2012)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
by: Roberts, Chrissy h., et al.
Published: (2014)

KIR And HLA Haplotype Analysis in a Family Lacking The KIR 2DL1-2DP1 Genes
by: Vojvodić Svetlana, et al.
Published: (2015-06-01)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
by: Vojvodić, S, et al.
Published: (2015)

KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections
by: Qi, Ying, et al.
Published: (2006)

Understanding how combinations of HLA and KIR genes influence disease
by: Rajagopalan, Sumati, et al.
Published: (2005)

Analysis of the expression of KIR and HLA-Cw in a Northeast Han population
by: HAN, YU, et al.
Published: (2013)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
by: Thobakgale, CF, et al.
Published: (2012)

KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
by: Cariani, Elisabetta, et al.
Published: (2013)

Impact of multiplicity of functional KIR-HLA compound genotypes on hepatocellular carcinoma
by: Tanimine, Naoki, et al.
Published: (2015)

Distribution of HLA-A, -B, and -C Alleles and HLA/KIR Combinations in Han Population in China
by: Shen, Yunsong, et al.
Published: (2014)

HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions
by: Magaret, Amalia, et al.
Published: (2016)

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
by: González-Galarza, Faviel F., et al.
Published: (2015)

Role of Kir2.1 in human monocyte‐derived foam cell maturation
by: Zhang, Wei, et al.
Published: (2015)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
by: Moesta, Achim K., et al.
Published: (2012)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
by: Denzin, Lisa K., et al.
Published: (1996)

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
by: Hutchison, Colin A, et al.
Published: (2012)

Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes
by: Li, Hongchuan, et al.
Published: (2015)

A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia
by: Sheereen, Atia, et al.
Published: (2011)

Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression
by: Barbour, Jason D, et al.
Published: (2007)

Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success
by: Hiby, Susan E., et al.
Published: (2004)

A role for activatory KIR/HLA complexes in HIV-associated Kaposi’s sarcoma development
by: Agostini, Simone, et al.
Published: (2011)

Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
by: Alter, Galit, et al.
Published: (2007)

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
by: Yawata, Makoto, et al.
Published: (2006)

KIR and HLA Loci Are Associated with Hepatocellular Carcinoma Development in Patients with Hepatitis B Virus Infection: A Case-Control Study
by: Pan, Ning, et al.
Published: (2011)

KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
by: Seich al Basatena, Nafisa-Katrin, et al.
Published: (2011)

KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy
by: Soria, Alessandro, et al.
Published: (2011)

Activating KIR and HLA Bw4 Ligands Are Associated to Decreased Susceptibility to Pemphigus Foliaceus, an Autoimmune Blistering Skin Disease
by: Augusto, Danillo G., et al.
Published: (2012)

KIR2DL4 (CD158d): An activation receptor for HLA-G
by: Rajagopalan, Sumati, et al.
Published: (2012)

Immunoinformatic Docking Approach for the Analysis of KIR3DL1/HLA-B Interaction
by: Grifoni, Alba, et al.
Published: (2013)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
by: Parsons, MS, et al.
Published: (2012)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
by: Nowak, Izabela, et al.
Published: (2012)

HIV-1 p24 derived epitopes modulate KIR2DL2-binding to HLA-Cw03
by: van Teijlingen, NH, et al.
Published: (2012)

Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy
by: De Re, Valli, et al.
Published: (2014)

Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
by: Erbe, A K, et al.
Published: (2013)